PharmiWeb4h
Paragon Health IT to Elevate Imaging as a Service Offering With Advanced Performance Monitoring and Workflow Automation
SACRAMENTO, CA / ACCESSWIRE / November 19, 2024 / Paragon Health IT today announced a collaboration with Dell Technologies.
PharmiWeb7h
WoundZoom Announces Launch of the WoundZoom LIGHT Mobile Application for Post Acute Care
BOCA RATON, FL / ACCESSWIRE / November 19, 2024 / WoundZoom is thrilled to introduce WoundZoom LIGHT, a HIPAA-compliant point ...
PharmiWeb9h
Thermosome Presents Encouraging Initial Clinical Data from Phase I Trial of Lead Compound THE001
THE001 safe and well tolerated in first two dose level, demonstrating encouraging signs of clinical activityData presented at ...
PharmiWeb8h
Could medical imaging innovation be the catalyst for precision medicine?
We all have a unique face, fingerprint, voice and signature, so why wouldn’t we have a unique response to the medicine and ...
PharmiWeb11h
Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland
Abbott today marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony ...
PharmiWeb4h
Owen Mumford Awarded Safety Phlebotomy and Specimen Collection Products Agreement With Premier, Inc.
MARIETTA, GA / ACCESSWIRE / November 19, 2024 / Owen Mumford has been awarded a national group purchasing agreement for Safety Phlebotomy and Specimen Collection Products with Premier, Inc. Effective ...
PharmiWeb7h
Protagonist Therapeutics to Host Conference Call to Announce an Oral Peptide IL-17 Antagonist Development Candidate
Webcast and conference call to be held be on Thursday, November 21st at 4:30 pm ET, dial in information belowNEWARK, CA / ACCESSWIRE / November 19, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" ...
PharmiWeb6h
Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year - Europe”
Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Jaguar's novel oral plant-based prescription drug, in Europe for orphan and/or rare diseases SAN ...
PharmiWeb21h
enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
Company to Host a Conference Call with the PIs Presenting the Pivotal Trial Data on Wednesday, November 20 th at 2:00 PM Eastern Time - Click Here to Access IRVINE, CA / ACCESSWIRE / November 19, 2024 ...
PharmiWeb8h
CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary
With the New York cannabis market projected to surpass $5 billion by 2027, this acquisition positions CBDL for exponential revenue growth and expanded market dominance.SCOTTSDALE, AZ / ACCESSWIRE / ...
PharmiWeb9h
Modus Therapeutics Receives Approval to Initiate a Phase IIa Clinical Trial for Chronic Kidney Disease (CKD)
As previously communicated, the planned Phase IIa study will be conducted in two parts. Part 1 aims to establish dosage levels and safety of sevuparin through single doses in 25-30 patients with ...
PharmiWeb8h
Bionoid Pharma, Inc. Launches Enhanced Supplements Ltd. to Drive Strategic E-Commerce Expansion
TORONTO, ON / ACCESSWIRE / November 19, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) is excited to announce the incorporation of its wholly owned subsidiary, Enhanced Supplements Ltd., a ...